Competencies by care stage
Follow-up
Longer-term check-ins, maintenance, and relapse monitoring after the active treatment window.
175 competencies mapped to this stage.
Looking for something specific? Ask Blossom
Informed consent, decisional capacity, autonomy, and withdrawal rights
Teaches how to obtain and maintain valid informed consent through clear disclosure, comprehension checks, capacity support, voluntariness, non-coercion, and respect for refusal or withdrawal. The competency also covers consent for screening procedures, recordings, collateral contact, rescue interventions, and documentation of the consent process.
4 roles · 59 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreConfidentiality, privacy, and research data protection
Teaches protection of participant identity, sensitive clinical or occupational information, recordings, and research data. The competency covers coded identifiers, restricted access, secure handling, confidentiality safeguards, and privacy-preserving documentation.
5 roles · 53 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreScreening, eligibility, and readiness assessment
Teaches how to assess clinical suitability before psychedelic or ketamine treatment, including medical and psychiatric screening, readiness evaluation, contraindication review, inclusion/exclusion criteria, and ongoing eligibility re-checks before dosing.
8 roles · 52 guidelines · 15 courses · 12 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreAcute psychological response and emergency management during dosing
Cluster covering 35 related competencies for monitoring acute psychological effects, recognising and managing distress, crisis containment, emergency escalation, and rescue-medication coordination during psychedelic dosing sessions.
6 roles · 51 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreAdverse event identification, documentation, and reporting
Teaches how to detect, elicit, document, and report adverse events and serious adverse events across the participant journey. The focus is accurate source documentation, regulatory reporting discipline, follow-up, and preservation of participant safety and trial integrity.
4 roles · 46 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 morePreparation and integration support
Cluster covering 31 related competencies including: Integration support, Integration therapy, Integration coaching.
7 roles · 43 guidelines · 18 courses · 14 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreSuicide and serious psychiatric risk assessment
Teaches structured assessment of suicidal ideation, intent, psychiatric deterioration, and related high-risk presentations. Learners are trained to use appropriate tools, safety planning, emergency contacts, clinician access, and escalation pathways when risk is identified.
6 roles · 41 guidelines · 1 courses · 1 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 moreManual fidelity, protocol adherence, and deviation management
Teaches faithful delivery of manualized treatment and protocol-defined procedures while documenting and managing unavoidable deviations. The competency protects participant welfare, treatment consistency, data integrity, and sponsor oversight.
5 roles · 39 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+4 morePost-dose follow-up, safety monitoring, and retention support
Teaches ongoing participant contact after dosing to support stability, detect delayed adverse effects, maintain therapeutic containment, and sustain adherence to follow-up visits and outcome assessments.
5 roles · 37 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreDischarge readiness, escort safety, and post-session supervision
Teaches how to determine when a participant is safe to leave after dosing and how to arrange appropriate supervision afterward. The competency covers psychological and physical stability, escort/support-person coordination, discharge restrictions, overnight or post-session support, and follow-up contact when needed.
4 roles · 30 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 moreBlinding, allocation concealment, and unblinding control
Teaches how to preserve blinded trial conduct across participant interactions, outcome collection, staff roles, and session procedures. The competency includes preventing accidental unblinding, minimizing bias, and using emergency unblinding only when clinically necessary.
6 roles · 29 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+4 moreMedication, substance-use, washout, and taper management
Teaches review and management of concomitant medications, restricted therapies, prohibited substances, washout periods, tapering requirements, and abstinence expectations. The competency includes participant counseling, medication reconciliation, sponsor notification, and team coordination when restrictions affect safety or interpretability.
5 roles · 29 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 moreStudy documentation, data integrity, and regulatory recordkeeping
Teaches accurate study documentation, source-record quality, secure data capture, Good Clinical Practice recordkeeping, IRB and sponsor documentation requirements, monitoring readiness, audit support, accountability, and retention obligations.
3 roles · 27 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreManualized psychedelic psychotherapy delivery
Teaches delivery of psychedelic-assisted psychotherapy according to an approved study manual across preparation, dosing, integration, and follow-up. The competency balances standardized structure with non-directive support for the participant’s therapeutic process.
4 roles · 25 guidelines · 3 courses · 2 providers
KetamineLSDMDMA+1 moreTherapeutic boundaries, professional conduct, and consent for touch
Teaches how to maintain clear relational and physical boundaries in emotionally vulnerable treatment settings. This includes professional conduct, rapport without overreach, explicit consent for touch, the right to revoke consent, and strict prohibition of sexual or erotic contact.
7 roles · 24 guidelines · 4 courses · 3 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreCo-therapist and multidisciplinary team coordination
Teaches coordinated practice across co-therapists, physicians, psychiatrists, study coordinators, principal investigators, and other care-team members. The focus is shared responsibility, clear communication, role clarity, and coordinated observation of participant status.
4 roles · 24 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 morePhysical safety monitoring
Cluster covering 3 related competencies including: Physical safety monitoring, Safety monitoring during dosing sessions, Medical safety monitoring during psilocybin administration.
5 roles · 19 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+2 moreAcute psychiatric and behavioral risk monitoring
Teaches continuous monitoring for distress, confusion, psychotic symptoms, suicidality, agitation, and other acute behavioral risks during and after dosing. The focus is early recognition, documentation, and escalation to clinical support when risk emerges.
5 roles · 17 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 morePreparation support
Cluster covering 11 related competencies including: Preparation support, Psilocybin preparation, Therapeutic preparation.
3 roles · 16 guidelines · 6 courses · 5 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreEthical conduct in human-subject research
Able to practice ethically in a clinical trial environment involving a Schedule-sensitive psychoactive intervention. This includes protecting participants, adhering to protocol, and supporting valid informed participation.
3 roles · 16 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineLSD+3 moreSupportive nondirective therapeutic stance
Cluster covering 6 related competencies including: Therapeutic support during dosing, Nondirective dosing-session presence, Supportive dosing-session facilitation.
2 roles · 16 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaMDMA+1 moreTherapeutic alliance building
Cluster covering 2 related competencies including: Therapeutic alliance building, Therapeutic alliance and rapport building.
2 roles · 15 guidelines · 1 courses · 1 providers
5-MeO-DMTDMT / AyahuascaMDMA+1 morePsilocybin session facilitation
Cluster covering 9 related competencies including: Psilocybin facilitation, Psilocybin session support, Psilocybin facilitation basics.
6 roles · 14 guidelines · 6 courses · 5 providers
LSDPsilocybinAdverse effects and side-effect management
Teaches recognition and management of expected and unexpected side effects during psychedelic or ketamine treatment. The competency emphasizes active observation, supportive response, and clinical escalation when symptoms exceed routine tolerability.
6 roles · 14 guidelines · 1 courses · 1 providers
DMT / AyahuascaIbogaineKetamine+3 morePsychedelic-assisted psychotherapy preparation and integration
Teaches structured pre-dose preparation and post-dose integration as the therapeutic frame for psychedelic-assisted psychotherapy. The therapist supports rapport, intention clarification, meaning-making, emotional processing, and consolidation of insights after dosing.
6 roles · 13 guidelines · 2 courses · 2 providers
5-MeO-DMTDMT / AyahuascaKetamine+3 moreHallucinogen pharmacology and effects
Cluster covering 7 related competencies including: Physiologic safety awareness, Hallucinogen pharmacology and effects, Hallucinogen-assisted therapy knowledge.
4 roles · 13 guidelines · 0 courses · 0 providers
LSDPsilocybinKetamine psychotherapy delivery
Cluster covering 12 related competencies including: KAP psychotherapy delivery, Ketamine and KAP knowledge, Ketamine integration planning.
6 roles · 12 guidelines · 7 courses · 5 providers
KetamineDissociation and acute neuropsychiatric effect monitoring
Teaches recognition and documentation of dissociation, psychosis-like symptoms, mania, and other acute neuropsychiatric effects that can occur after ketamine, psychedelic dosing, or related interventions. The focus is monitoring, reporting, and escalation when symptoms become clinically significant.
5 roles · 12 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineKetamine+1 morePhysiologic monitoring, thermoregulation, hydration, and overdose response
Teaches monitoring and response for acute physiological risks, including vital signs, temperature, hydration, overheating, excessive fluid intake, and suspected overdose. The competency emphasizes supportive care, medical coordination, documentation, and escalation when needed.
6 roles · 11 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineMDMA+1 moreSpecial-interest adverse event vigilance
The protocol requires active monitoring for psychedelic-specific adverse events such as hallucinations, psychotic symptoms, dissociation, mood alteration, and cognitive disturbance. These require immediate notification and follow-up.
3 roles · 11 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+3 moreDepression symptom and remission monitoring
Teaches structured monitoring of depressive symptoms, response, and remission across treatment and follow-up. Learners use standardized scales and clinical review to track change and identify deterioration or non-response.
2 roles · 10 guidelines · 0 courses · 0 providers
IbogaineKetamineLSD+1 moreMindfulness, intention-setting, set and setting, and somatic presence
Teaches practices that support preparation and therapeutic presence, including mindfulness, intention-setting, body-aware attention, environmental preparation, mindset awareness, and regulation through somatic presence.
6 roles · 9 guidelines · 7 courses · 6 providers
5-MeO-DMTDMT / AyahuascaIbogaine+4 moreTrauma-informed therapeutic presence and somatic support
Teaches a trauma-informed stance during psychedelic work, including calm presence, non-verbal reassurance, body-aware support, somatic orientation, and containment through difficult experiences while maintaining safety and boundaries.
2 roles · 9 guidelines · 2 courses · 2 providers
KetamineMDMAPsilocybinComprehensive psychiatric assessment
Ability to perform or supervise detailed psychiatric evaluation for diagnosis, eligibility, and ongoing monitoring. The therapist/facilitator must understand symptom presentations relevant to MDD, AUD, suicidality, psychosis, and dissociation.
3 roles · 9 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+2 moreEnsure confidentiality and session containment
Maintain a contained therapeutic environment that protects the patient’s privacy and minimizes unwanted exposure. The session structure emphasizes confidentiality and controlled access to stimulation and outside contact.
2 roles · 9 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineMDMA+1 moreGrounding and regulation techniques
Therapists must be able to teach and coach grounding practices that help participants regulate during preparation and dosing. These methods are used before medication and during distress.
2 roles · 9 guidelines · 0 courses · 0 providers
MDMAPsilocybinOutcome Measure and Assessment Literacy
Teaches clinicians and research staff to understand the purpose, limits, scoring, interpretation, and clinical meaning of psychological measures and study instruments used to evaluate symptoms, functioning, safety, and treatment outcomes.
3 roles · 9 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+2 moreContinuation, discontinuation, and risk-benefit judgment
Teaches how clinicians determine whether a participant should proceed, pause, discontinue dosing, or terminate study participation. The competency centers on safety-driven clinical judgment, risk-benefit assessment, and early termination when continuation is no longer appropriate.
5 roles · 8 guidelines · 0 courses · 0 providers
KetamineMDMAPsilocybinParticipant safety restriction counseling
Teaches how to instruct participants on post-dose and study-period restrictions that reduce risk from impaired judgment, unsafe activity, prohibited substances, or behaviors that could confound study outcomes.
3 roles · 8 guidelines · 0 courses · 0 providers
5-MeO-DMTIbogaineKetamine+2 morePsychological support during altered states
Provides supportive therapeutic presence while the patient is under the influence of ketamine. Uses calming, noncoercive guidance to help the patient navigate dissociation and emotional material.
3 roles · 8 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+3 moreTraining and competency maintenance
Therapists and study personnel are expected to receive structured training and ongoing supervision. Competence includes both protocol adherence and the ability to work safely and consistently across sites.
3 roles · 8 guidelines · 0 courses · 0 providers
MDMAPsilocybinUse outcome assessment and follow-up to evaluate response
The study used standardized anxiety measures and followed patients for 2 months and 12 months, implying competence in tracking outcomes over time. Therapists should be able to assess symptom change and sustained benefit using structured follow-up.
2 roles · 8 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+2 moreVital sign and physical distress monitoring
Monitors participant physical status during study visits and identifies concerning changes requiring escalation. Vital signs and symptomatic changes are part of routine safety observation.
4 roles · 8 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+1 moreCultural humility, Indigenous respect, and equity-oriented care
Teaches culturally responsive psychedelic care, including humility, anti-bias practice, Indigenous and traditional-use awareness, cultural appropriation concerns, diversity and inclusion, and respectful work with marginalized communities.
6 roles · 7 guidelines · 11 courses · 10 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreClinical Interviewing and PTSD Assessment
Teaches structured clinical interviewing and assessment administration for PTSD and related symptom domains, including symptom severity, functional impairment, risk factors, and appropriate use of standardized assessment tools.
2 roles · 7 guidelines · 0 courses · 0 providers
KetamineMDMAParticipant-centered discharge planning and aftercare
Support decision-making about ongoing treatment after trial completion, particularly for participants who received escitalopram. The clinician helps participants consider whether to continue, taper, or return to usual care.
3 roles · 7 guidelines · 0 courses · 0 providers
IbogaineKetamineMDMA+1 moreIntegration and post-session debriefing
Cluster covering 4 related competencies including: Integration and debriefing, Integration and debriefing facilitation, Integration and post-session debriefing.
2 roles · 6 guidelines · 0 courses · 0 providers
DMT / AyahuascaPsilocybinReproductive risk, contraception, and pregnancy monitoring
Teaches counseling and monitoring around contraception, reproductive restrictions, pregnancy risk, and pregnancy-related discontinuation rules. Learners are trained to explain requirements clearly and respond promptly when pregnancy or reproductive-safety concerns arise.
2 roles · 6 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaKetamine+1 morePsilocybin psychotherapy framework
Cluster covering 4 related competencies including: Psychedelic therapy workflow, Psilocybin psychotherapy framework, Psilocybin-assisted psychotherapy framework.
6 roles · 5 guidelines · 4 courses · 2 providers
DMT / AyahuascaKetaminePsilocybinEthical psychedelic facilitation
Cluster covering 3 related competencies including: Ethical psychedelic facilitation, Safe, legal psychedelic care facilitation, Ethical decision-making in psychedelic facilitation.
7 roles · 5 guidelines · 2 courses · 2 providers
5-MeO-DMTIbogaineKetamine+1 moreAssessment administration and interpretation
Ability to administer and interpret structured interviews, clinician ratings, and self-report measures used in the study. Therapists contribute to eligibility, safety, and outcome assessment.
2 roles · 5 guidelines · 0 courses · 0 providers
LSDPsilocybinParticipant education and informed consent communication
Clinicians and research staff must clearly educate participants about study procedures, risks, side effects, restrictions, and possible benefits, and obtain written informed consent before screening and study participation. Ethical delivery depends on transparent communication and opportunities for questions.
2 roles · 5 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineKetamine+2 moreParticipant safety planning and support network coordination
Can identify and involve support persons, attendants, and outside providers to enhance safety. The facilitator must coordinate practical supports while respecting confidentiality and protocol boundaries.
3 roles · 5 guidelines · 0 courses · 0 providers
MDMAPsilocybinProvide overnight and next-day containment
Therapists must ensure continuity of care after the acute session, including overnight observation and next-morning integration before discharge. This reflects a containment and recovery responsibility beyond the dosing period.
3 roles · 5 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineLSD+2 moreResearch assessment administration
Administer study measures and structured assessments on schedule, including psychological, spiritual, and neurobehavioral instruments. This includes both paper-based and Storyline-based assessments.
2 roles · 5 guidelines · 0 courses · 0 providers
KetamineMDMAPsilocybinTrauma-focused exposure facilitation
Facilitate trauma exposure in a structured, supportive, and protocol-consistent manner. The therapist must be able to initiate, pace, and process exposure work while maintaining adherence to PE methods.
2 roles · 5 guidelines · 0 courses · 0 providers
KetamineMDMAProfessional self-care and burnout prevention
Teaches sustainable self-care practices for clinicians and facilitators working in emotionally intense settings. The competency supports emotional resilience, ethical boundaries, reflective practice, and burnout prevention.
5 roles · 4 guidelines · 3 courses · 3 providers
KetamineMDMAPsilocybinRisk evaluation and safety monitoring
Teaches continuous evaluation of clinical risk and maintenance of a safe care environment throughout preparation, dosing, and follow-up. Learners monitor risk signals, apply safety procedures, and escalate care when needed.
6 roles · 4 guidelines · 3 courses · 2 providers
5-MeO-DMTIbogaineKetamine+2 moreAddiction and OUD treatment knowledge
Facilitator must understand opioid use disorder, medication-assisted treatment, and the clinical rationale for adjunctive psychotherapy. The protocol frames MORE+KAP as an investigational augmentation to buprenorphine treatment.
2 roles · 4 guidelines · 0 courses · 0 providers
IbogaineKetaminePsilocybinFacilitate integration of experience into behavioral change
Cluster covering 2 related competencies including: Integration of psychedelic experience with behavior change, Facilitate integration of experience into behavioral change.
2 roles · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTPsilocybinIndependent outcome assessment administration
The facilitator must administer and coordinate patient-rated and clinician-rated measures while minimizing bias. Assessments should be completed independently and in the correct order.
3 roles · 4 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineKetamine+1 moreMonitor acute and short-term adverse effects
The study emphasizes the absence of acute or chronic adverse effects persisting beyond 1 day and no treatment-related serious adverse events, indicating the need for active monitoring during and after treatment. Facilitators must be able to observe, document, and respond to adverse reactions.
2 roles · 4 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaIbogaine+1 moreNonintrusive session monitoring and containment
Facilitators must balance active safety monitoring with minimal interference in the participant’s inner experience. The role includes maintaining continuous presence, periodic check-ins, and preserving the therapeutic container of the session.
2 roles · 4 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineMDMA+1 morePrioritize participant wellbeing over research aims
Participant safety and wellbeing must take precedence over scientific objectives at all times. Therapists must communicate and operationalize this priority throughout screening, treatment, and follow-up.
3 roles · 4 guidelines · 0 courses · 0 providers
DMT / AyahuascaMDMAPsilocybin psychoeducation
Cluster covering 2 related competencies including: Psilocybin psychoeducation, Psychedelic psychoeducation and expectation management.
2 roles · 4 guidelines · 0 courses · 0 providers
MDMAPsilocybinSubstance use assessment
Ability to evaluate alcohol and other substance use patterns using standardized tools and clinical interview. This is essential for eligibility, safety, and outcome monitoring.
2 roles · 4 guidelines · 0 courses · 0 providers
IbogaineKetamineMDMA+1 moreSafety monitoring and emergency awareness
The page points to checklists and a guide to basic medical emergencies, indicating that learners should be able to monitor safety and recognize urgent issues. The overall training context also stresses keeping both client and practitioner safe.
5 roles · 3 guidelines · 1 courses · 1 providers
DMT / AyahuascaIbogaineMDMAAssess outcomes and psychological change
The framework implies competence in evaluating both symptom change and subjective outcomes over time. The study used standardized anxiety measures and qualitative interviews to assess sustained effects and patient-reported change.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaIbogaineLSDBehavioral monitoring and outcome assessment
Collect smoking-related behavioral data and participant-reported outcomes repeatedly across the trial. Facilitators must accurately gather self-report, breath CO, urine, and questionnaire data according to protocol.
3 roles · 3 guidelines · 0 courses · 0 providers
LSDPsilocybinEmpathic presence and listening
Therapists must listen with nonjudgmental, emotionally attuned presence and convey validation, reassurance, and curiosity. They should be able to stay relaxed yet engaged, including noticing nonverbal cues and responding without prying.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaMDMAInterdisciplinary coordination across mental health and medical services
Combined ketamine infusion and PE treatment requires coordination between psychotherapy providers and medical/anesthesia or medication administration staff. Effective collaboration supports timing, safety oversight, and protocol fidelity.
3 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineMindfulness instruction
Facilitator can teach and cue mindfulness practices consistent with the study protocol. Mindfulness is presented as present-moment, nonjudgmental awareness.
2 roles · 3 guidelines · 0 courses · 0 providers
KetamineMDMAPsilocybinPre-treatment clinical risk assessment
Understand the major medical risks associated with ibogaine administration, especially cardiac and neurologic toxicity, before proceeding with treatment. This includes recognizing that ibogaine has been linked to torsades de pointes, QTc prolongation, bradycardia, and ataxia.
3 roles · 3 guidelines · 0 courses · 0 providers
IbogaineSubstance use relapse monitoring
Ability to monitor for opioid use recurrence, other substance use, and ketamine misuse during the trial. The clinician must recognize relapse risk and take action when substance use worsens.
2 roles · 3 guidelines · 0 courses · 0 providers
KetamineTherapeutic rapport and engagement support
Help patients engage in emotionally intense trauma-focused treatment and reduce dropout risk. The therapist should recognize comorbid depression or anxiety that may interfere with adherence and response.
2 roles · 3 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineMDMAUnderstanding of trial procedures and schedule
Know the sequence, timing, and purpose of screening, preparation, dosing, scanning, follow-up, and unblinding visits. The therapist/facilitator must be able to work within the full protocol structure.
2 roles · 3 guidelines · 0 courses · 0 providers
MDMAPsilocybinVoluntary participation and non-coercion
The handbook explicitly states that the experience should be fully explained and that the subject should accept it voluntarily. Coercion is framed as both unethical and therapeutically counterproductive.
2 roles · 3 guidelines · 0 courses · 0 providers
5-MeO-DMTIbogaineLSDHarm reduction and risk awareness
Cluster covering 5 related competencies including: Harm-reduction orientation, Harm reduction and risk awareness, Harm reduction for client support.
7 roles · 2 guidelines · 5 courses · 5 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 moreDosing-day facilitation
Cluster covering 2 related competencies including: Dosing-day facilitation, Dosing-session facilitation.
4 roles · 2 guidelines · 2 courses · 2 providers
DMT / AyahuascaKetaminePsilocybinLegal and Regulatory Navigation
Teaches practitioners to identify and apply relevant legal, regulatory, ethical, and institutional requirements, including documentation, consent, reporting, controlled-substance, and jurisdiction-specific obligations.
6 roles · 2 guidelines · 2 courses · 2 providers
IbogaineKetamineMDMA+1 moreFacilitator self-awareness and self-care
The program includes facilitator development and self-care, and it explicitly calls on learners to recognize personal limitations and seek support. This suggests training in reflective practice and professional self-management.
3 roles · 2 guidelines · 1 courses · 1 providers
DMT / AyahuascaMDMAPsilocybinACT-based case formulation
Therapists must understand participant distress through an Acceptance and Commitment Therapy lens and use that formulation throughout preparation, dosing, and integration. They identify psychological inflexibility processes and track movement toward or away from psychological flexibility.
1 role · 2 guidelines · 0 courses · 0 providers
PsilocybinAction planning and relapse-prevention support
Helps participants convert motivation into specific behavior-change strategies. Uses structured planning tools and individualized modules to address triggers, coping, and alternative behaviors.
2 roles · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinAssessment of emotional stability after sessions
Therapists must remain with participants at the end of and immediately after experimental sessions until emotional stability is established. This requires real-time clinical judgment about readiness for reduced supervision.
4 roles · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaMDMACoordination with community recovery supports
For alcohol use problems, the handbook expects therapists to connect subjects with Alcoholics Anonymous and similar social supports, framing the psychedelic experience as an introduction rather than a cure. This is a competency in continuing care planning.
2 roles · 2 guidelines · 0 courses · 0 providers
IbogaineLSDLaboratory safety monitoring
Review laboratory and biomarker data for clinically significant abnormalities, including chemistry, hematology, coagulation, and alcohol biomarkers. This supports medical safety surveillance during follow-up.
2 roles · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaManage mandated reporting and safety concerns
Therapists/facilitators must fulfill professional legal duties and escalate safety or reporting concerns promptly.
2 roles · 2 guidelines · 0 courses · 0 providers
KetamineMDMAManagement of assessment-related distress
Because interviews and questionnaires may provoke emotional reactions or fatigue, facilitators must respond supportively and mitigate burden. This includes addressing distress during assessments and offering breaks.
2 roles · 2 guidelines · 0 courses · 0 providers
MDMAPsilocybinMedication conversion and detoxification workflow
Coordinate the conversion from opioid maintenance treatment to morphine-sulphate prior to ibogaine dosing, reflecting the treatment sequence described in the study. This requires careful timing and clinical oversight.
2 roles · 2 guidelines · 0 courses · 0 providers
IbogaineMonitor broad domains of well-being beyond symptom reduction
Safety monitoring in this context includes tracking not only adverse psychiatric states but also broader psychological, emotional, existential, and spiritual outcomes. Clinicians should watch for changes across multiple domains that may affect patient functioning and care needs.
1 role · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaPsilocybinMotivational interviewing and enhancement
Uses motivational interviewing methods to strengthen intrinsic motivation and commitment to change. Tailors discussions to the participant’s ambivalence, goals, and readiness to change drinking behavior.
2 roles · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinNighttime and overnight participant support
When overnight stays are required, facilitators and attendants must maintain safe observation and supportive presence without acting as outside therapists. They need to monitor comfort, safety, and emergency access overnight.
2 roles · 2 guidelines · 0 courses · 0 providers
MDMANon-responder handoff and continuity of care
The facilitator must ensure non-responders are transitioned safely back to clinical care. Continuity of care is explicitly required to support ongoing psychiatric treatment.
2 roles · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinPE protocol delivery
Deliver manualized Prolonged Exposure therapy according to the study protocol and standard PE structure. This includes sequencing psychoeducation, in vivo exposure, imaginal exposure, homework review, and relapse prevention across sessions.
1 role · 2 guidelines · 0 courses · 0 providers
KetaminePractice within evidence limitations and communicate uncertainty
Therapists should accurately represent the current evidence base and avoid overstating efficacy or durability. The article notes significant short-term benefit but also the need for larger multicenter trials and longer follow-up.
2 roles · 2 guidelines · 0 courses · 0 providers
IbogainePsilocybinProtocol adherence and visit scheduling
Ability to manage the study schedule, windows, and follow-up procedures accurately. This supports treatment delivery and valid outcome collection.
2 roles · 2 guidelines · 0 courses · 0 providers
DMT / AyahuascaKetamineRelapse prevention psychotherapy delivery
Deliver ongoing relapse prevention psychotherapy after dosing through the post-dose follow-up period. The approach is used to support alcohol recovery and translate treatment effects into behavior change.
1 role · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaRetention and engagement skills
Given the risk of high attrition, facilitators need strong engagement and follow-up skills. The protocol explicitly notes the importance of respecting time commitments, tracking procedures, and strong interpersonal skills of study personnel.
1 role · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTKetamineShared decision-making and referral coordination
Collaborates with patients, medical practitioners, and referring providers to support individualized care. Helps patients consider alternatives and coordinate ongoing treatment needs.
3 roles · 2 guidelines · 0 courses · 0 providers
IbogaineKetamineTreatment-condition matching and support
Deliver comparable behavioral support across psilocybin and NRT conditions while respecting protocol differences. Facilitators must maintain treatment fidelity and avoid bias toward one arm.
2 roles · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinUse of ACT and adjunctive psychotherapies
Apply Acceptance and Commitment Therapy as the primary psychotherapeutic framework, while using other modalities as clinically indicated. The protocol also references CBT, psychodynamic approaches, and Internal Family Systems.
1 role · 2 guidelines · 0 courses · 0 providers
KetaminePsilocybinUse of structured rating scales
The therapist/facilitator or designated rater must administer and interpret multiple structured clinical scales reliably. Training and separation of roles are required to preserve rating quality and blinding.
3 roles · 2 guidelines · 0 courses · 0 providers
5-MeO-DMTDMT / AyahuascaValues clarification and committed action coaching
Therapists must help participants identify, recover, and translate values into concrete behavior change. The manual treats values work as central to depression recovery and integration.
2 roles · 2 guidelines · 0 courses · 0 providers
PsilocybinWorking with family/collateral supports
The protocol expects involvement of relatives in follow-up, indicating a facilitator competency in engaging collateral supports. This helps verify outcomes and sustain recovery monitoring.
2 roles · 2 guidelines · 0 courses · 0 providers
IbogaineKetaminePsychedelic research literacy and evidence appraisal
Teaches how to interpret the psychedelic clinical evidence base, compare strength of evidence across indications, understand mechanism theories, and critically appraise research claims. The competency supports evidence-informed practice rather than relying on general field narratives.
7 roles · 1 guidelines · 11 courses · 8 providers
IbogaineKetamineLSD+2 moreIntegration support and meaning-making
Cluster covering 2 related competencies including: Integration support and meaning-making, Meaning-making and integration support.
4 roles · 1 guidelines · 4 courses · 4 providers
KetaminePsilocybinTrauma-informed care
Cluster covering 2 related competencies including: Trauma-informed care, Trauma-informed psychedelic care.
4 roles · 1 guidelines · 4 courses · 4 providers
KetaminePsilocybinPsychedelic integration support
Cluster covering 2 related competencies including: Psychedelic integration support, Psychedelic knowledge integration.
4 roles · 1 guidelines · 2 courses · 2 providers
DMT / AyahuascaPsychotherapeutic facilitation methods
Cluster covering 2 related competencies including: Facilitation of psychedelic journeys, Psychotherapeutic facilitation methods.
4 roles · 1 guidelines · 2 courses · 2 providers
LSDPsilocybinPsychedelic harm reduction and integration fundamentals
Cluster covering 2 related competencies including: Psychedelic harm reduction and integration therapy, Psychedelic harm reduction and integration fundamentals.
5 roles · 1 guidelines · 2 courses · 1 providers
KetamineLSDMDMA+1 moreTrauma-informed practice
Cluster covering 2 related competencies including: Trauma-informed practice, Trauma-informed clinical practice.
2 roles · 1 guidelines · 2 courses · 1 providers
MDMAPsilocybinConfidentiality and trust maintenance
The course explicitly discusses confidentiality, especially in underground practice and with anonymous practitioners. Learners are expected to understand confidentiality as a core part of maintaining safe and effective psychedelic care relationships.
4 roles · 1 guidelines · 1 courses · 1 providers
LSDAftercare planning
Develop follow-up care after the acute ibogaine period to support behavior change and relapse prevention. The manual emphasizes that the treatment session alone is not enough for long-term recovery.
1 role · 1 guidelines · 0 courses · 0 providers
IbogaineAlcohol abstinence screening and enforcement
Ensure required abstinence conditions are met before dosing and make clinical judgments about rescheduling or exclusion when they are not. This protects safety and protocol integrity.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaAlcohol use disorder clinical knowledge
Have a working understanding of moderate to severe AUD, relapse processes, craving, withdrawal, and common comorbidities. This knowledge is required to deliver the integrated treatment model safely and effectively.
2 roles · 1 guidelines · 0 courses · 0 providers
5-MeO-DMTAssess psychosocial functioning
Competent delivery includes monitoring psychosocial functioning in addition to depressive symptoms. The source reports psychosocial functioning as a treatment outcome sustained through follow-up.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinAttention to participant experience and perceived coercion
Therapists and research facilitators should evaluate how participants experienced study involvement, including perceived costs, benefits, and pressure to participate. This reflects an ethical responsibility to monitor the quality and voluntariness of participation over time.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMABehavioral assessment administration
Trained staff must administer and/or supervise a battery of behavioral tasks and self-report instruments consistently across baseline and drug sessions. Some measures are verbally administered by clinicians or coordinators and require standardized delivery.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMACBT expertise for mood disorders
Clinicians must have working expertise in evidence-based CBT for depression and related mood conditions, including the ability to deliver core CBT components across preparation, post-session integration, and relapse prevention phases. The protocol assumes competence in standard CBT delivery as the psychosocial backbone of treatment.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinCheck-in and timing of interventions during sessions
Therapists must skillfully time check-ins and interventions to sustain process without unnecessary intrusion. They monitor silence, talking, avoidance, and signs of internal engagement to decide when to inquire, redirect, or simply witness.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAConduct structured follow-up assessments
After completion of PE, patients are assessed over a 3-month follow-up period at multiple time points, requiring clinician or facilitator competence in longitudinal follow-up procedures. This includes maintaining contact and collecting outcome information consistently.
1 role · 1 guidelines · 0 courses · 0 providers
KetamineConfidential and accurate data collection
Collects and records substance use, withdrawal, and follow-up data accurately and responsibly in clinical or research settings.
2 roles · 1 guidelines · 0 courses · 0 providers
IbogaineDocumentation of subjective experience
The therapist/facilitator must record participant-reported effects and clinically relevant observations accurately. Documentation supports both safety monitoring and outcome interpretation.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaHome-practice coaching
Facilitator supports between-session practice and adherence to study procedures. Participants are expected to practice skills daily and complete smartphone-based EMA.
1 role · 1 guidelines · 0 courses · 0 providers
KetamineIdentify early improvement and dropout risk during PE
The study examines whether early improvement during PE relates to dropout rates, implying a competency in recognizing early response patterns and engagement risk. Therapists should monitor participation closely and intervene to support retention when possible.
1 role · 1 guidelines · 0 courses · 0 providers
KetamineIntegrate experiences into daily life change
Therapists should help patients carry session experiences into durable changes in habits, relationships, values, and quality of life. Reported lasting effects included reduced anxiety, increased openness, patience, boundaries, and shifts in priorities.
2 roles · 1 guidelines · 0 courses · 0 providers
LSDKnowledge of psychedelic session structure
Facilitators need to understand the full treatment sequence and how each phase contributes to safety and treatment delivery. The intervention depends on correct sequencing and timing.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinKnowledge of therapeutic mechanism and expected time course
The therapist/facilitator should know the expected onset, peak, and persistence of effects to guide monitoring and interpretation. The source reports acute effects with follow-up improvements lasting days.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaLost-to-follow-up procedures
The facilitator must make repeated documented efforts to contact participants who miss visits. Follow-up processes differ for responders and non-responders.
1 role · 1 guidelines · 0 courses · 0 providers
KetamineMaintain a post-session safety net
Therapists must provide continuity, availability, and clear support structures after MDMA sessions to reduce anxiety and manage emerging difficulties. This safety net extends beyond the dosing day.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMAMonitor symptom outcomes beyond PTSD
The protocol includes secondary outcomes for depression and anxiety severity, so clinicians should be able to assess and track these domains alongside PTSD symptoms. This broadens case monitoring and supports comprehensive clinical oversight.
2 roles · 1 guidelines · 0 courses · 0 providers
KetamineNon-leading symptom inquiry
Ask about symptoms and adverse effects in a neutral, non-suggestive manner. This reduces bias and improves safety detection in a vulnerable oncology population.
2 roles · 1 guidelines · 0 courses · 0 providers
KetamineOverdose, misuse, and abuse-liability vigilance
Facilitators are expected to monitor for signs of misuse, diversion, dependence, or other abuse-related phenomena even though the medication is administered only on-site. They must also recognize protocol violations or dropout patterns that may signal abuse liability concerns.
1 role · 1 guidelines · 0 courses · 0 providers
MDMAProvide protocol-consistent patient education and informed framing
Clinicians should present the intervention accurately as ketamine- or midazolam-augmented PE within a research protocol, with clear explanation of purpose and expectations. Ethical practice includes avoiding overstatement of benefit and framing treatment as investigational augmentation of an established therapy.
1 role · 1 guidelines · 0 courses · 0 providers
KetaminePsychological support during integration
Therapists should support evaluation, emotional processing, and integration after the acute experience. This includes helping patients reflect without over-directing or interrupting the process.
1 role · 1 guidelines · 0 courses · 0 providers
IbogaineRecognition of participant functional status and recovery
Facilitators should understand that treatment aims include symptom reduction and improved functioning. Support work should attend to both emotional processing and real-world disability.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinRelapse-prevention support
Help patients navigate craving, relapse risk, and post-treatment vulnerability. The manual notes that fear of relapse is more realistic than fear of withdrawal after ibogaine.
2 roles · 1 guidelines · 0 courses · 0 providers
IbogaineResearch visit scheduling and follow-up coordination
Coordinate multi-visit assessment timelines around the psilocybin session. Follow-up data collection is essential for longitudinal outcomes and requires careful scheduling.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinResearch-professional role separation
Distinguish psychotherapy/facilitation functions from outcome assessment and other research tasks. Separation reduces bias and protects the integrity of blinded assessments.
2 roles · 1 guidelines · 0 courses · 0 providers
MDMARisk management for vulnerable bereaved participants
Therapists must monitor a clinically vulnerable population experiencing recent loss and possible PGD risk. The protocol requires special attention to psychological destabilization, distress, and functional impairment.
2 roles · 1 guidelines · 0 courses · 0 providers
DMT / AyahuascaTask instruction and coaching
Prepare participants to complete emotional processing tasks and questionnaires accurately. Staff must teach task procedures and ensure participants understand expectations before scanning and follow-up assessments.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinTherapeutic treatment planning
Ability to plan and structure treatment for patients receiving LSD-assisted psychotherapy. The clinician must organize sessions, timing, and therapeutic objectives appropriately.
1 role · 1 guidelines · 0 courses · 0 providers
LSDUnderstanding of bipolar-specific risk context
The facilitator must understand why bipolar II participants require enhanced monitoring and conservative dosing. The protocol is built around the risk of mood destabilization in this population.
1 role · 1 guidelines · 0 courses · 0 providers
PsilocybinUnderstanding of study schedule and visit procedures
Facilitators must know the study timeline to conduct therapy and safety checks at the correct times. They should understand which visits are in person, virtual, or questionnaire-only and what assessments occur at each stage.
1 role · 1 guidelines · 0 courses · 0 providers
PsilocybinUse of observation and assessment tools
The therapist should assess both the immediate experience and longer-term change, using structured observation, self-report, and reports from others where possible. The handbook treats evaluation as difficult but necessary for understanding therapeutic effects.
1 role · 1 guidelines · 0 courses · 0 providers
LSDUse patient-reported outcomes in clinical evaluation
The study relied on self-reported symptomatology, so clinicians should understand how to gather and interpret patient-reported outcomes relevant to psychiatric and existential distress. This includes using subjective reports as meaningful indicators while recognizing their limits.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinWithdrawal and craving support
Monitor and address nicotine withdrawal symptoms and smoking urges across the treatment window. Facilitators help participants manage discomfort and sustain abstinence through high-risk periods.
2 roles · 1 guidelines · 0 courses · 0 providers
PsilocybinCase-based practice, peer consultation, and professional learning community
Teaches applied competence through role play, case discussion, peer consultation, seminars, mentorship, and learning-community structures. The emphasis is translating theory into practice, receiving feedback, and developing reflective clinical judgment with peers.
7 roles · 0 guidelines · 8 courses · 7 providers
KetaminePsilocybinEthics and ethical practice
Cluster covering 4 related competencies including: Ethical practice, Ethics in psychedelic care, Ethics and ethical practice.
6 roles · 0 guidelines · 4 courses · 3 providers
MDMAPsilocybinProfessional application and practice development
Teaches practitioners how to translate psychedelic-informed training into professional practice, including applied skill development, scope awareness, practice-building considerations, and integration of competencies into real clinical or wellness settings.
5 roles · 0 guidelines · 2 courses · 2 providers
Legal access pathways and care-team coordination
Teaches how participants move through lawful access routes and coordinated care pathways. The competency covers referral navigation, team handoffs, and the practical steps needed to connect eligible participants with appropriate treatment or study settings.
6 roles · 0 guidelines · 2 courses · 1 providers
MDMAPsilocybinPsilocybin prescribing fundamentals
Cluster covering 2 related competencies including: Psilocybin prescribing fundamentals, Prescribing fundamentals for psychedelic treatment.
2 roles · 0 guidelines · 2 courses · 1 providers
MDMAPsilocybinApprenticeship and mentor shadowing
The program includes supervised apprenticeship hours with pre-approved mentors. Learners are expected to observe, assist, and translate training into supervised practice.
4 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinClinical documentation and coordination
Some listed programs explicitly teach clinical documentation and related practice management skills. This suggests learners may be expected to document care, coordinate treatment processes, and work within structured clinical workflows.
3 roles · 0 guidelines · 1 courses · 1 providers
KetamineMDMAPsilocybinClinical trial training and feedback use
The page highlights best-in-class clinical training for drug trials and AI-supported evaluation. Learners are expected to refine skills quickly and receive targeted feedback in training or evaluation contexts.
6 roles · 0 guidelines · 1 courses · 1 providers
Collaborative work with adjunctive clients
Learners are taught how to work with clients who already have an outside therapist and to coordinate closely with existing treatment. The course also mentions treatment flow for groups and couples.
3 roles · 0 guidelines · 1 courses · 1 providers
KetamineCollaborative-care role awareness
The program emphasizes that it prepares people for therapeutic and facilitative roles within a collaborative care framework, not independent medical practice. Learners are expected to understand role boundaries, especially around prescribing and administration.
5 roles · 0 guidelines · 1 courses · 1 providers
KetaminePsilocybinCompound comparison for therapeutic use
The course teaches learners to distinguish between classic psychedelics and emerging therapies within therapeutic applications. This is a foundational comparative literacy competency rather than a protocol-specific skill.
6 roles · 0 guidelines · 1 courses · 1 providers
KetamineLSDMDMA+1 moreCoordination and documentation using checklists and manuals
The page repeatedly points learners to manuals, checklists, PDFs, and reference materials, indicating a practical emphasis on coordination and structured preparation. This suggests learners should be able to organize session materials and support process consistency.
4 roles · 0 guidelines · 1 courses · 1 providers
Debriefing and reflective practice
The practicum includes retreat team debriefs, supervisor meetings, and assessment presentations. This signals an expectation that learners can reflect on practice, receive feedback, and integrate learning.
5 roles · 0 guidelines · 1 courses · 1 providers
Equitable Access and Inclusive Service Delivery
Teaches providers to recognise access barriers and health disparities, adapt services for diverse participant needs, and deliver care in ways that are inclusive, accessible, culturally responsive, and practically reachable.
4 roles · 0 guidelines · 1 courses · 1 providers
Mentorship and professional development
Each trainee works with a mentor, and mentoring includes professional development discussions, role plays, and networking. This indicates structured support for building practice readiness and professional identity.
4 roles · 0 guidelines · 1 courses · 1 providers
Microdosing and macrodosing protocol design
Learners are taught to design custom protocols for both microdosing and macrodosing based on client goals. The page also references microdosing formulas and practical application of timing and dosage nuances.
3 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinPeer consultation and collaborative learning
Vital emphasizes study groups, peer interaction, and faculty-led sessions. Learners are expected to collaborate with others, receive feedback, and improve their practice through community learning.
4 roles · 0 guidelines · 1 courses · 1 providers
Professional development and directory readiness
Learners are guided to earn badges and join a professional directory, showing an emphasis on professional identity, discoverability, and readiness to be found by clients and industry leaders. This is a practice-facing career competency rather than a clinical one.
3 roles · 0 guidelines · 1 courses · 1 providers
Professional identity and licensing readiness
The page repeatedly frames the program as preparing learners for licensure and professional practice in Oregon. Learners are expected to understand practice context, licensure requirements, and professional transitions.
4 roles · 0 guidelines · 1 courses · 1 providers
PsilocybinSafety and legal boundaries awareness
The page includes explicit warnings about what graduates can and cannot legally do. Learners are expected to understand scope limits, licensure requirements, and when consultation supervision is needed.
5 roles · 0 guidelines · 1 courses · 1 providers
KetamineMDMAPsilocybinSafety-oriented documentation and templates
Trainees receive templates such as consent and intake forms, informational documents, and guidelines, which implies competence in using standardized practice materials. The page also signals procedural support for safe and organized care delivery.
5 roles · 0 guidelines · 1 courses · 1 providers
KetamineStructured PAP process navigation
The course teaches the overall PAP workflow from screening through follow-up. Learners are expected to understand and explain each phase of treatment in a structured way.
4 roles · 0 guidelines · 1 courses · 1 providers
KetamineSupervised practicum and feedback integration
Students complete 50 supervised practicum hours and receive expert feedback while working with real clients. This is intended to translate theory into competent applied practice.
4 roles · 0 guidelines · 1 courses · 1 providers
Supporting diverse spiritual and community contexts
The program states it prepares facilitators to address the needs of clients, patients, or community members from diverse faith traditions and communities of origin. Learners are expected to adapt facilitation to varied settings and worldviews.
3 roles · 0 guidelines · 1 courses · 1 providers
Sustainable practice development and prescriber coordination
The course teaches practical steps to launch and sustain a KAP practice, including forging relationships with prescribers and identifying suitable practicum sites. This is framed as part of professional development and business planning.
4 roles · 0 guidelines · 1 courses · 1 providers
KetamineUse of complementary support methods
Students explore how psychedelics can be integrated with supportive methods such as breathwork, meditation, cold therapy, and neurofeedback. The course emphasizes a holistic toolkit rather than a single-method approach.
3 roles · 0 guidelines · 1 courses · 1 providers
Therapeutic support in patient care settings
The page highlights extensive patient care experience and a background in holistic counseling psychology, suggesting practical competence in supporting participants in clinical or care environments. This is more general care-setting competence than protocol-specific technique.
4 roles · 0 guidelines · 0 courses · 1 providers
General psychedelic-assisted practice skills
Catch-all cluster covering 189 general competencies for psychedelic-assisted clinical practice that did not group into a more specific category — including miscellaneous facilitation, monitoring, ethics, safety, regulatory awareness, group support, and program-specific skills not captured by dedicated clusters elsewhere.
8 roles · 45 guidelines · 27 courses · 18 providers
5-MeO-DMTDMT / AyahuascaIbogaine+5 more
Other care stages
Follow the competency map across the care pathway.